Verona, NJ, United States of America

Laura L Verbiar

This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura L Verbiar. Retrieved from https://idiyas.com/inventor/laura-l-verbiar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura L Verbiar: Innovator in Antihypertensive Peptides

Introduction

Laura L Verbiar is a notable inventor based in Verona, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of hydrophobic peptides with antihypertensive activity. Her work has the potential to impact the treatment of hypertension in mammals.

Latest Patents

Laura holds a patent for hydrophobic peptides that exhibit antihypertensive properties. The patent details pharmaceutical compositions that include these peptides and outlines a method for treating mammalian hypertension by administering the hydrophobic peptide to hypertensive mammals. This innovation represents a promising advancement in hypertension treatment.

Career Highlights

Laura is associated with Schering Corporation, where she has been able to apply her expertise in pharmaceutical research and development. Her work at the company has allowed her to focus on innovative solutions for health-related challenges.

Collaborations

Throughout her career, Laura has collaborated with notable colleagues, including Michael F Czarniecki and Timothy Kogan. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Laura L Verbiar is a pioneering inventor whose work on hydrophobic peptides is paving the way for new treatments for hypertension. Her contributions to the pharmaceutical industry are noteworthy and reflect her commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…